首页> 外文OA文献 >Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide

【2h】

Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide

机译：HSCT后使用氟达拉滨，白消安和胸腺球蛋白的结果：与以白消安和环磷酰胺为条件的同种异体移植的匹配比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Bredeson Christopher N.; Zhang Mei-Jie; Agovi Manza-A.; Bacigalupo Andrea; Bahlis Nizar J.; Ballen Karen; Brown Christopher; Chaudhry M. Ahsan; Horowitz Mary M.; Kurian Seira; Quinlan Diana; Muehlenbien Catherine E.; Russell James A.; Savoie Lynn; Rizzo J. Douglas; Stewart Douglas A.;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. [J] . Bredeson CN, Zhang MJ, Agovi MA, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2008,第9期

机译：使用氟达拉滨，白消安和胸腺球蛋白进行HSCT后的结果：与以白消安和环磷酰胺为条件的同种异体移植的比较。
2. Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia [J] . Saraceni Francesco, Beohou Eric, Labopin Myriam, American Journal of Hematology . 2018,第10期

机译：Thiotepa，Busulfan和Fludarabine与Busulfan和环磷酰胺相比，作为异构干细胞移植来自匹配的兄弟姐妹和急性髓细胞白血病的无关供体的调理方案
3. Comparison Between Busulfan with Cyclophosphamide and Busulfan with Fludarabine As Myeloablative Conditioning of Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies [J] . Mori Takehiko, Ohashi Kazuteru, Kanamori Heiwa, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：白消安与环磷酰胺和白消安与氟达拉滨作为同种异体造血干细胞移植治疗骨髓恶性肿瘤的清髓条件的比较
4. Intravenous Busulfan Reduces Toxicity Associated with Myeloablative Allogeneic Hematopoietic Transplantation in Patients with Myeloid Malignancies [C] . A. Shimoni, B. Bxelorai, I. Hardan, European Haematology Association . 2002

机译：静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
5. Children with acute leukemia: A comparison of outcomes and cost-effectiveness from allogeneic blood stem cell and bone marrow transplantation. [D] . Lin, Yu-Feng. 2009

机译：儿童急性白血病：同种异体造血干细胞和骨髓移植的疗效和成本效益比较。
6. OUTCOMES FOLLOWING HCT USING FLUDARABINE BUSULFAN AND THYMOGLOBULIN: A MATCHED COMPARISON TO ALLOGENEIC TRANSPLANTS CONDITIONED WITH BUSULFAN AND CYCLOPHOSPHAMIDE [O] . Christopher N. Bredeson, Mei-Jie Zhang, Manza-A. Agovi, -1

机译：使用氟达拉滨BUSULFAN和胸腺球蛋白进行HCT后的结果：与BUSULFAN和环磷酰胺组成的同种异体移植物的匹配比较
7. 304: Effect of Substituting Fludarabine and Thymoglobulin for Cyclophosphamide in Busulfan-based Conditioning Regimens on T-cell Chimerism and outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT) [O] . ODonnell P.V., Woolfrey A.E., Storer B., 2008

机译：304：以异丁硫醇为基础的调理方案中的氟达拉滨和胸腺球蛋白替代环磷酰胺对异基因造血细胞移植（HCT）后T细胞嵌合和预后的影响

Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide

著录项

引文网络

相似文献

相关主题

期刊订阅